Clinical Trials Browser

Phase 1 × Uveal Melanoma × ADI PEG20 × Clear all

NCT03922880 2025-05-15

Study of Immunotherapy Plus ADI-PEG 20 for the Treatment of Advanced Uveal Melanoma

Phase 1 Completed

Uveal Melanoma

NCT02029690 2020-09-25

TRAP

Phase 1 Terminated

CNSDermatologicGastrointestinal

Uveal Melanoma, Carcinoma, Glioma, Carcinoma, Hepatocellular

NCT01665183 2016-02-25

Ph 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma

Phase 1 Completed

DermatologicGynecologic

Uveal Melanoma, Melanoma, Ovarian Neoplasms